Education
About Us
Working with TipRanks
Follow Us
VolitionRX Ltd. (VNRX)
:VNRX
Earnings Data
Report Date
Mar 31, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.05Last Year’s EPS
-0.06Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlighted significant progress in revenue growth, cost management, and strategic partnerships with major companies like Werfen and Hologic. Scientific advancements also promise future potential. However, challenges remain, such as unpredictable revenue and uncertainty in closing additional licensing agreements.Company Guidance
Revenue Growth
Revenue for the third quarter grew 32% over the same quarter last year, reaching $0.6 million.
Cost Management
Operating expenses for the quarter were down 10% year-on-year and down 18% for the first three quarters.
Partnership with Werfen
VolitionRx signed a research license and exclusive commercial option rights agreement with Werfen for antiphospholipid syndrome (APS), potentially opening a market of approximately $85 million annually.
Partnership with Hologic
A co-marketing and service agreement with Hologic to promote Nu.Q Discover services, leading to the first sale by Hologic.
Scientific Advancements
Significant progress in the Capture-Seq project, potentially a revolutionary new liquid biopsy method for cancer detection.
Cash Flow Improvement
Net cash used in operating activities was $3.6 million for the quarter, down 33% over the same period last year.
VNRX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
VNRX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 13, 2025 | $0.35 | $0.33 | -5.71% |
Aug 14, 2025 | $0.64 | $0.69 | +7.81% |
May 15, 2025 | $0.45 | $0.43 | -4.44% |
Mar 31, 2025 | $0.57 | $0.52 | -8.77% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does VolitionRX Ltd. (VNRX) report earnings?
VolitionRX Ltd. (VNRX) is schdueled to report earning on Mar 31, 2026, After Close (Confirmed).
What is VolitionRX Ltd. (VNRX) earnings time?
VolitionRX Ltd. (VNRX) earnings time is at Mar 31, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is VNRX EPS forecast?
VNRX EPS forecast for the fiscal quarter 2025 (Q4) is -0.05.